Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NTR

Assessing the Bearish Sentiment Surrounding Nutrien

This afternoon we watched Nutrien drop -1.4% to a price of $52.5 per share. The Large-Cap Agricultural Inputs company is now trading -13.65% below its average target price of $60.8. Analysts have set target prices ranging from $50.0 to $70.0 per share for Nutrien, and have given the stock an average rating of buy.

Nutrien's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4.4%. The stock's short ratio is 9.57. At 0.03%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation.

Another number to watch is the company's rate of institutional share ownership, which now stands at 68.9%. In conclusion, we believe there is mixed market sentiment regarding Nutrien.

Institutions Invested in Nutrien

Date Reported Holder Percentage Shares Value
2024-12-31 Royal Bank of Canada 6% 29,678,223 $1,558,106,707
2024-12-31 Vanguard Group Inc 4% 19,778,500 $1,038,371,250
2024-12-31 Bank of Montreal /CAN/ 3% 13,857,124 $727,499,010
2024-12-31 Dodge & Cox Inc 3% 12,523,259 $657,471,097
2025-03-31 Silchester International Investors LLP 2% 10,634,539 $558,313,297
2024-12-31 1832 Asset Management L.P. 2% 10,619,367 $557,516,767
2024-12-31 FMR, LLC 2% 9,874,324 $518,402,010
2024-12-31 First Eagle Investment Management, LLC 2% 9,529,311 $500,288,827
2024-12-31 Mackenzie Financial Corporation 2% 7,800,691 $409,536,277
2024-12-31 Canada Pension Plan Investment Board 2% 7,502,128 $393,861,720
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS